Updated Post Marketing studies with vernakalant in patients with AF <48 hrs treated in ED

עודכן בתאריך: 4 באוגוסט 2019

Post-Marketing-Data-graph

לתוצאות הפוסט מרקטינג בארץ לחצו כאן

AF=Atrial fibrillation; Flec=Flecainide; Ibut=Ibutilide; SR=Sinus Rhythm; ver=Vernakalant

  1. Costabel, PACE 2015;38(2):196-200
  2. Juul-Moller; Eur J Cardiovasc Med, 2013;2(4) 226-233
  3. Simon; Europace. 2017 Feb 1;19(2):233-240
  4. Pohjantähti-Maaroos, Eur Heart J Acute Cardiovasc Care. 2017 Aug 1:, doi: 10.1177/2048872617728558
  5. Stoneman; Ir J Med Sci. 2017 Feb 6. doi: 10.1007/s11845-017-1576-1
  6. Cosin Sales; Rev Esp Cardiol (Engl Ed). 2016 Jun;69(6):619-20
  7. Carbajosa Dalmau J et al. Emergencias 2017;29 8: Kriz; Am J Emerg Med. 2016 Aug;34(8):1486-90
  8. Kriz; Am J Emerg Med. 2016 Aug;34(8):1486-90
  9. Jameel Mohsen MD¹, Jalal Ashkar MD¹ , Simcha Meisel MD, Avraham Shotan MD, Mark Kazatsker MD 2018 August ;Emed 7/2019